Lakeside Advisors INC. lowered its position in shares of Solventum Co. (NYSE:SOLV – Free Report) by 7.5% in the 4th quarter, Holdings Channel reports. The fund owned 6,987 shares of the company’s stock after selling 565 shares during the period. Lakeside Advisors INC.’s holdings in Solventum were worth $462,000 as of its most recent filing with the SEC.
A number of other large investors have also modified their holdings of the company. Exchange Traded Concepts LLC bought a new position in Solventum in the 3rd quarter worth approximately $60,000. Foundations Investment Advisors LLC bought a new position in shares of Solventum in the third quarter worth $345,000. Sequoia Financial Advisors LLC increased its holdings in shares of Solventum by 8.3% during the third quarter. Sequoia Financial Advisors LLC now owns 5,737 shares of the company’s stock valued at $400,000 after purchasing an additional 441 shares during the period. Eastern Bank bought a new stake in shares of Solventum during the third quarter valued at about $105,000. Finally, Waldron Private Wealth LLC acquired a new stake in Solventum in the third quarter worth about $72,000.
Wall Street Analyst Weigh In
SOLV has been the topic of several research analyst reports. Mizuho assumed coverage on shares of Solventum in a research note on Wednesday, December 4th. They set a “neutral” rating and a $70.00 target price on the stock. Piper Sandler increased their price objective on shares of Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a report on Friday, November 8th. Finally, Morgan Stanley boosted their target price on Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a report on Monday, November 11th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $68.29.
Solventum Stock Up 0.6 %
SOLV stock opened at $74.44 on Friday. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $96.05. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The firm has a 50 day simple moving average of $71.07 and a 200 day simple moving average of $68.95.
Solventum Profile
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Featured Stories
- Five stocks we like better than Solventum
- Using the MarketBeat Stock Split Calculator
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Buy P&G Now, Before It Sets A New All-Time High
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- What is the Hang Seng index?
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Want to see what other hedge funds are holding SOLV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Solventum Co. (NYSE:SOLV – Free Report).
Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.